Purchases from this Verified User are protected by Buyerxpo.com's Buyer Protection Programme.
Product Description
Cetilistat (ATL-962), also known as Cetilistat, is a new gastrointestinal lipase inhibitor developed by Alizyme, a British company. NorginaBV acquired the global marketing rights to Chemicalbook Cetilistat. Celestat is undergoing phase 3 clinical trials in the United States. In Japan, neollistat was approved for the treatment of obesity in September 2013 in collaboration with Takeda Pharmaceuticals. The product is called "Oblean."
ITEM SPECIFICATION RESULT
Appearance White, crystalline powder or colorless crystals Conforms
Identification Accord With BP2007 Conforms
Assay 98.5%~101.0% 99.97%
Melting point 75°C~78°C 77°C
Optical rotation -0.05°~+0.05° 0.00°
Heavy metals ? 0.001% <0.001%
Related substances
Impurity B ? 0.3% Conforms
Any other impurity ? 0.3% Conforms
Total of all impurities apart
from impurity B
? 0.7% Passes
Impurity F ? 0.1% Not detected
Sulphated ash ? 0.1 0.02%
